U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863713) titled 'Early Intervention for High Risk Premyopic Children' on Oct. 02.
Brief Summary: The purpose of this research project is to add evidence of pharmacological (0.025% atropine) and optical (Defocus Integrated Multiple Segments Triple Enhanced Design spectacle lenses ) approaches for myopia prevention among premyopic preschoolers, which may contribute to a better understanding of the intervention strategy for myopia control in premyopic children.
Study Start Date: Oct. 24
Study Type: INTERVENTIONAL
Condition:
Myopia
Intervention:
DRUG: 0.025% atropine eye drops
Daily instillation of 0.025% atropine
DEVICE: DIMS TED
Stepwise weari...